University of Chicago
1,137
189
282
593
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
17.0%
193 terminated/withdrawn out of 1137 trials
75.4%
-11.1% vs industry average
9%
102 trials in Phase 3/4
49%
288 of 593 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (1137)
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
Role: lead
Behavioral Treatment and Memantine in Body Focused Repetitive Behaviors
Role: lead
Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
Role: collaborator
Continuous Glucose Monitoring to Detect Postpartum Dysglycemia in Patients With Gestational Diabetes
Role: lead
Semaglutide (Wegovy) Treatment for Trichotillomania
Role: lead
A Clinical Trial of Tolcapone in Obsessive Compulsive Disorder
Role: lead
Valbenazine in Obsessive Compulsive Disorder
Role: lead
BRIDGE-US: Bridging Readiness in Deployed Neurotrauma Gaps for Excellence
Role: lead
Caplyta in Borderline Personality Disorder
Role: lead
A Study of the Natural Progression of Interstitial Lung Disease (ILD)
Role: lead
Recovery Legal Care Clinical Trial
Role: lead
Inhaler Trainer Efficacy Study
Role: collaborator
Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence
Role: collaborator
Low-dose Tocilizumab Versus Standard of Care in Hospitalized Patients With COVID-19
Role: lead
Study of Acetazolamide With Temozolomide in Adults With Newly Diagnosed or Recurrent Malignant Glioma
Role: lead
Achieving Routine Intervention and Screening for Emotional Health
Role: lead
AYA OMGYES Sexual Health Study
Role: lead
Surgical Myomectomy Followed by Oral Myfembree Versus Standard of Care Trial (SOUL)
Role: lead
Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)
Role: lead
Physical Activity Intervention for Black Women With Asthma
Role: lead